These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [New technologies for vaccine development]. Leclerc C Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228 [TBL] [Abstract][Full Text] [Related]
9. Vaccinology of classical swine fever: from lab to field. van Oirschot JT Vet Microbiol; 2003 Nov; 96(4):367-84. PubMed ID: 14599784 [TBL] [Abstract][Full Text] [Related]
10. Attenuation Methods for Live Vaccines. Hajra D; Datey A; Chakravortty D Methods Mol Biol; 2021; 2183():331-356. PubMed ID: 32959252 [TBL] [Abstract][Full Text] [Related]
11. Vaccines based on structure-based design provide protection against infectious diseases. Thomas S; Luxon BA Expert Rev Vaccines; 2013 Nov; 12(11):1301-11. PubMed ID: 24090172 [TBL] [Abstract][Full Text] [Related]
12. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction. Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878 [TBL] [Abstract][Full Text] [Related]
13. New concepts in vaccine development in malaria. Kanoi BN; Egwang TG Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043 [TBL] [Abstract][Full Text] [Related]
14. Feasible improvements in vaccines in the Expanded Programme on Immunization. McIntosh K Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097 [TBL] [Abstract][Full Text] [Related]
15. DNA vaccines: a review. Lewis PJ; Babiuk LA Adv Virus Res; 1999; 54():129-88. PubMed ID: 10547676 [TBL] [Abstract][Full Text] [Related]
16. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines. Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H mBio; 2019 Sep; 10(5):. PubMed ID: 31530680 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of live vaccines by co-delivery of immune modulating proteins. Manohar MM; Campbell BE; Walduck AK; Moore RJ Vaccine; 2022 Sep; 40(40):5769-5780. PubMed ID: 36064671 [TBL] [Abstract][Full Text] [Related]
18. Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Rocha CD; Caetano BC; Machado AV; Bruna-Romero O Int Microbiol; 2004 Jun; 7(2):83-94. PubMed ID: 15248156 [TBL] [Abstract][Full Text] [Related]
19. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Zuckermann FA; Martin S; Husmann RJ; Brandt J Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035 [TBL] [Abstract][Full Text] [Related]
20. Universal vaccines: shifting to one for many or shooting too high too soon! Hamad M APMIS; 2011 Sep; 119(9):565-573. PubMed ID: 21851413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]